PBLS insider transaction filings

Parabilis Medicines, Inc. — 16 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-22. Screen PBLS transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-224RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 98,433 @ $27.13 · Purchase (P): 32,987 @ $27.72 · Purchase (P): 21,696 @ $27.96 · Purchase (P): 6,504 @ $29.17 · Purchase (P): 37,723 @ $30 · Purchase (P): 47,250 @ $29.77EDGAR
2026-06-294Levy Guy — 10% owner
Soleus Private Equity Fund III, L.P. — 10% owner
Soleus Private Equity GP III, LLC — 10% owner
Soleus PE GP III, LLC — 10% owner
Soleus Capital Management, L.P. — 10% owner
Soleus GP, LLC — 10% owner
Soleus Capital Master Fund, L.P. — 10% owner
Soleus Capital, LLC — 10% owner
Soleus Capital Group, LLC — 10% owner
Purchase (P): 375,000 @ $20 · Purchase (P): 125,000 @ $20 · Conversion (C): 527,070 @ $9.48 · Conversion (C): 527,070 (derivative) @ $0EDGAR
2026-06-164SEBULSKY ALAN — DirectorPurchase (P): 8,435 @ $27.67 · Purchase (P): 5,000 @ $26.00 · Purchase (P): 4,065 @ $27.10EDGAR
2026-06-154Borisy Alexis — DirectorConversion (C): 105,414 · Conversion (C): 162,221 (derivative)EDGAR
2026-06-154RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Conversion (C): 6,556,740 · Conversion (C): 1,187,881 · Purchase (P): 19,728,353 @ $20 · Purchase (P): 1,460,397 @ $20 · Conversion (C): 642,250 (derivative) · Conversion (C): 160,562 (derivative) · +2 moreEDGAR
2026-06-154FITZGERALD EDWARD M — DirectorConversion (C): 5,539 · Conversion (C): 3,878 · Conversion (C): 5,271 · Conversion (C): 5,332 (derivative) · Conversion (C): 3,666 (derivative) · Conversion (C): 8,111 (derivative)EDGAR
2026-06-154SEBULSKY ALAN — DirectorPurchase (P): 12,500 @ $20EDGAR
2026-06-114Weber Barbara — DirectorGrant/award (A): 20,215 (derivative) @ $0EDGAR
2026-06-114Simson Jake — DirectorGrant/award (A): 20,215 (derivative) @ $0EDGAR
2026-06-114Klausner Richard — DirectorGrant/award (A): 20,215 (derivative) @ $0EDGAR
2026-06-114Yeshwant Krishna — DirectorGrant/award (A): 20,215 (derivative) @ $0EDGAR
2026-06-114Borisy Alexis — DirectorGrant/award (A): 20,215 (derivative) @ $0EDGAR
2026-06-114RA CAPITAL MANAGEMENT, L.P. — Director
RA Capital Healthcare Fund LP — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director
Shah Rajeev M. — Director
Grant/award (A): 20,215 (derivative) @ $0EDGAR
2026-06-114FITZGERALD EDWARD M — DirectorGrant/award (A): 20,215 (derivative) @ $0EDGAR
2026-06-114SEBULSKY ALAN — DirectorGrant/award (A): 39,792 (derivative) @ $0EDGAR
2026-06-114Flynn James E — 10% owner
Deerfield Mgmt HIF, L.P. — 10% owner
DEERFIELD MANAGEMENT COMPANY, L.P. — 10% owner
Deerfield Healthcare Innovations Fund, L.P. — 10% owner
Deerfield Mgmt III, L.P. — 10% owner
Deerfield Private Design Fund III, L.P. — 10% owner
Conversion (C): 122,990 · Conversion (C): 122,990 · Conversion (C): 149,238 · Conversion (C): 149,238 · Conversion (C): 260,992 · Conversion (C): 260,992 · +10 moreEDGAR

Recent 8-K events — Parabilis Medicines, Inc.

FiledFormItems reportedSource
2026-08-138-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-118-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PBLS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →